You are here

Capital Markets

Navigating the global capital markets

International securities offerings and listings are complex and require innovative solutions in increasingly competitive markets for capital.

We provide the world's leading companies, institutional investors and strategic shareholders and investment banks with advice on transactions and policy, empowering them with confidence to manage capital and mitigate risk.

As our practice is balanced between issuer and underwriter mandates, our clients receive commercial, insightful advice from capital markets specialists with technical expertise and a complete understanding of both sides of transactions. We advise on the full range of debt, equity and equity-linked capital markets transactions across jurisdictions globally. Working together with experts in competition, disputes, employment, finance, real estate and tax, we identify and solve all challenges that may arise.

Transaction types include initial public offerings (IPOs), secondary fundraisings (including rights issues, placings and open offers), investment grade bonds, Euro medium-term note (EMTN) programmes, regulatory capital, liability management, exchangeable and convertible bonds, Securities and Exchange Commission (SEC)-registered offerings, high-yield bonds, Sukuk, sovereign and quasi-sovereign issues and structured securitisations (see securitisation and structured finance).

Our full service offering encompasses a wide range of products and sectors including banks, energy, infrastructure and transport, mining, pharmaceuticals and healthcare, real estate and technology, media and communications.

Diverse knowledge and in-depth expertise

Insights and updates

In Capital Markets
27th May 2022
The Financial Conduct Authority (FCA) has published a discussion paper ( DP22/2 ) in which...
11th March 2022
The Treasury has published a response on the UK Prospectus Review, setting out its policy...
17th December 2021
The Treasury has published a summary of responses to its consultation on a proposed new...

主要联系人

Related news and deals

15 December 2022

Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务

01 December 2022

Herbert Smith Freehills advises joint sponsors on Lygend's Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为力勤资源香港上市提供法律服务

11 November 2022

Herbert Smith Freehills renews China leadership to strengthen business 史密夫斐尔焕新中国管理层 加强中国业务

08 November 2022

Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务